List of Tables
    Table 1. Dolutegravir CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dolutegravir Market Trends
    Table 3. Dolutegravir Market Drivers
    Table 4. Dolutegravir Market Challenges
    Table 5. Dolutegravir Market Restraints
    Table 6. Global Dolutegravir Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dolutegravir Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dolutegravir Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dolutegravir Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dolutegravir Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dolutegravir Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dolutegravir Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dolutegravir Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Dolutegravir Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dolutegravir Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Dolutegravir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dolutegravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir as of 2021)
    Table 18. Top Players of Dolutegravir in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dolutegravir Product Type
    Table 20. Date of International Manufacturers Enter into Dolutegravir Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dolutegravir Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dolutegravir Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dolutegravir Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dolutegravir Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Dolutegravir Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dolutegravir Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dolutegravir Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Dolutegravir Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Dolutegravir Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dolutegravir Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dolutegravir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Dolutegravir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dolutegravir Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Dolutegravir Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dolutegravir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Dolutegravir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dolutegravir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Dolutegravir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dolutegravir Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Dolutegravir Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. ViiV Healthcare (GSK) Corporation Information
    Table 43. ViiV Healthcare (GSK) Description and Business Overview
    Table 44. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. ViiV Healthcare (GSK) Dolutegravir Product
    Table 46. ViiV Healthcare (GSK) Recent Development
    Table 47. Shanghai Desano Pharmaceuticals Corporation Information
    Table 48. Shanghai Desano Pharmaceuticals Description and Business Overview
    Table 49. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Shanghai Desano Pharmaceuticals Product
    Table 51. Shanghai Desano Pharmaceuticals Recent Development
    Table 52. Mylan Corporation Information
    Table 53. Mylan Description and Business Overview
    Table 54. Mylan Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Mylan Product
    Table 56. Mylan Recent Development
    Table 57. Aurobindo Pharma Corporation Information
    Table 58. Aurobindo Pharma Description and Business Overview
    Table 59. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Aurobindo Pharma Product
    Table 61. Aurobindo Pharma Recent Development
    Table 62. LAURUS Labs Corporation Information
    Table 63. LAURUS Labs Description and Business Overview
    Table 64. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. LAURUS Labs Product
    Table 66. LAURUS Labs Recent Development
    Table 67. Adcock Ingram Limited Corporation Information
    Table 68. Adcock Ingram Limited Description and Business Overview
    Table 69. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Adcock Ingram Limited Product
    Table 71. Adcock Ingram Limited Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. Dolutegravir Customers List
    Table 75. Dolutegravir Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dolutegravir Product Picture
    Figure 2. Global Dolutegravir Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dolutegravir Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dolutegravir Sales 2017-2028 (K Pcs)
    Figure 5. United States Dolutegravir Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dolutegravir Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dolutegravir Sales 2017-2028 (K Pcs)
    Figure 8. United States Dolutegravir Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dolutegravir Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Dolutegravir Report Years Considered
    Figure 11. Product Picture of 10mg Tablets
    Figure 12. Product Picture of 50mg Tablets
    Figure 13. Global Dolutegravir Market Share by Type in 2022 & 2028
    Figure 14. Global Dolutegravir Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Dolutegravir Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Dolutegravir Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Dolutegravir Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Dolutegravir Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Dolutegravir Market Share by Type in 2022 & 2028
    Figure 20. United States Dolutegravir Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Dolutegravir Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Dolutegravir Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Dolutegravir Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Dolutegravir Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Prevent HIV Infection Following Potential Exposure
    Figure 26. Product Picture of Other
    Figure 27. Global Dolutegravir Market Share by Application in 2022 & 2028
    Figure 28. Global Dolutegravir Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Dolutegravir Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Dolutegravir Sales by Application (2017-2028) & (K Pcs)
    Figure 31. Global Dolutegravir Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Dolutegravir Price by Application (2017-2028) & (USD/Pcs)
    Figure 33. United States Dolutegravir Market Share by Application in 2022 & 2028
    Figure 34. United States Dolutegravir Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Dolutegravir Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Dolutegravir Sales by Application (2017-2028) & (K Pcs)
    Figure 37. United States Dolutegravir Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Dolutegravir Price by Application (2017-2028) & (USD/Pcs)
    Figure 39. North America Dolutegravir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 40. North America Dolutegravir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Dolutegravir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. Europe Dolutegravir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Dolutegravir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 51. Asia-Pacific Dolutegravir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Dolutegravir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 63. Latin America Dolutegravir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Dolutegravir Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 68. Middle East & Africa Dolutegravir Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. U.A.E Dolutegravir Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Dolutegravir Value Chain
    Figure 73. Dolutegravir Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed